This little-known oncology stock could rise more than 70%, says Citi
Olema Oncology could be a leading player in developing therapies for women's cancer, particularly breast cancer, according to Citi Research.…
Olema Pharmaceuticals Inc.
Analysts Love These Biotech Stocks, Giving 4 an Over 100% Lead
The healthcare sector may have done poorly in recent years, but analysts are optimistic about it at the moment. “Just…